Targeting death receptors in chemo-resistant cancer cells

ASCO: Pemetrexed extends survival as maintenance therapy

ASCO: Lung cancer screening by low-dose computed tomography results in high rate of false positives

ASCO: Maintenance therapy for NSCLC

ASCO: Experimental targeted therapy improves progression-free survival for advanced NSCLC

Oestrogen and progestin therapy increases NSCLC risk

AACR 2009: Common genetic variations and predisposition to cancer

AACR 2009: 100 years of AACR

AACR 2009: Genetics of pleuropulmonary blastoma

Bacteria as agents to initiate potent anti-tumour activity

COSMOS lung cancer study

ECCO 15 - ESMO 34 Executive Scientific Programme Committee